ID
36624
Beschreibung
Study ID: 102394 Clinical Study ID: 102394 Study Title: A Phase IV, partially double-blind study to demonstrate non-inferiority of GSK Biologicals’ Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process) when administered as a single dose to subjects aged 2-30 yrs Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00227422 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed clinical study under GSK sponsorship. The product that is studied in this clinical study, together with the rights to the data and results generated, has been transferred by GSK to Pfizer. GSK’s Clinical Study Register is no longer maintained for this study. To request access to clinical study data from Pfizer, go here: http://www.pfizer.com/research/clinical_trials/trial_data_and_results Generic Name: Meningococcal Serogroups A, C, W-135 and Y Vaccine Trade Name: Mencevax Study Indication: Infections, Meningococcal
Link
http://www.pfizer.com/research/clinical_trials/trial_data_and_results
Stichworte
Versionen (1)
- 26.05.19 26.05.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
26. Mai 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Mencevax™ ACWY (new process) versus Mencevax™ ACWY (current process); NCT00227422
Concomitant Vaccination
- StudyEvent: ODM
Ähnliche Modelle
Concomitant Vaccination
- StudyEvent: ODM
C0042196 (UMLS CUI-2)
C0042196 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,2])
C2360065 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,3])
C0042196 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Keine Kommentare